Invention Grant
- Patent Title: Probiotic fermented cereal compositions and methods for treatment of gastrointestinal diseases caused by pro-inflammatory bacteria
- Patent Title (中): 益生菌发酵谷物组合物和由促炎细菌引起的胃肠道疾病的治疗方法
-
Application No.: US13826208Application Date: 2013-03-14
-
Publication No.: US09205114B2Publication Date: 2015-12-08
- Inventor: Hans Israelsen
- Applicant: Nordisk Rebalance A/S
- Applicant Address: DK Allerod
- Assignee: Nordisk Rebalance A/S
- Current Assignee: Nordisk Rebalance A/S
- Current Assignee Address: DK Allerod
- Agency: Posternak Blankstein & Lund LLP
- Priority: EP05388079 20050928; DK200600529 20060412
- Main IPC: A61K35/66
- IPC: A61K35/66 ; A61K31/685 ; A61K35/74 ; A61K35/745 ; A61K35/747 ; A61K45/06 ; A23L1/30 ; A23L1/172 ; A61K35/744 ; A61K36/899 ; A61K35/742

Abstract:
The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effector. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease.
Public/Granted literature
- US20130195821A1 Treatment of IBD and IBS Using Both Probiotic Bacteria and Fermented Cereal as Treatment Effectors Public/Granted day:2013-08-01
Information query